Approvals/TGA/COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 3 micrograms/0.3 mL concentrated suspension for injection multidose vial

Approved

STANDARD

COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 3 micrograms/0.3 mL concentrated suspension for injection multidose vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0142158de7cf42a9
Product Name: COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 3 micrograms/0.3 mL concentrated suspension for injection multidose vial
Artg Id: 457690
Artg Name: COMIRNATY JN.1 (bretovameran) COVID-19 VACCINE 3 micrograms/0.3 mL concentrated suspension for injection multidose vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2024-10-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c6e737e5c5f5973766879b959fcd0bce.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/10509e46e194184071ec7a3dcc3b3b7a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

0142158de7cf42a9

Type

Standard